OBO_ID (LABEL):	CHEBI_82625 (Trolox)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC5485024	3/2017	S93-PMC5485024	['caption (table-wrap): table 1\n\ncharacteristics of the study population in relation total antioxidant capacity (tac) of the diet ( n = 2359)selected exposure characteristicstertiles of the tac of the dieta p ‐valuebt1t2t3 n = 787 n = 786 n = 786orac, μmol te/day, median (min–max)6969(1768–8637)10 077(8644–11 510)13 624(11 516–33 097)boys, %57.248.544.3 <0.001 parental history of allergic disease, %33.331.629.20.20parental socio‐economic statusc, %84.385.386.50.48early maternal smoking, %14.112.012.00.34parental smoking at 8 years, %17.417.317.80.97noxexposure at 8 years ≥ median, %47.450.652.00.19dietary supplement use at 8 years, %42.041.443.70.65omega‐3 Intake (g/day)d, mean (sd)1.5 (0.32)1.5 (0.36)1.4 (0.34) 0.009 Omega‐6 intake (g/day)d, mean (sd)6.5 (1.27)6.7 (1.32)6.5 (1.40) 0.004 Vitamin D Intake (μg/day)d, mean (sd)5.6 (1.71)5.3 (1.78)5.0 (1.45) <0.001 reported allergic symptoms related to Fruits and vegetables intake at 8 years, %13.29.09.4 0.017\ntotal antioxidant capacity Intake (μmol Trolox equivalents/day) as measured with Oxygen Radical absorbance capacity assay, energy‐adjusted to 1900 kcal/day.']	N/A	N/A	[('CHEBI_37972', 'phosphorus-32 atom', 661, '3'), ('GO_0007631', 'feeding behavior', 663, 'intake'), ('CHEBI_34858', 'mupirocin calcium hydrate', 726, 'Omega'), ('CHEBI_52026', 'amorpha-4,11-diene', 732, '6'), ('CHEBI_28384', 'vitamin K', 797, 'Vitamin D'), ('GO_0007631', 'feeding behavior', 807, 'intake'), ('CHEBI_33290', 'food', 910, 'fruits'), ('GO_0007631', 'feeding behavior', 996, 'intake'), ('CHEBI_82625', 'Trolox', 1009, 'Trolox'), ('CHEBI_61073', 'oxygen radical', 1050, 'oxygen radical')]
PMC5485024	3/2017	S97-PMC5485024	['orac, Oxygen Radical absorbance capacity; te/day, Trolox equivalents per day; sd, standard deviations.john wiley & sons, ltd\nthe number of adolescents with onset of allergic diseases between 8 and 16 years (compared to children at risk at 8 years) were 191/2088 (9%) for asthma, 646/1811 (36%) for rhinitis, 428/1563 (27%) for sensitization to inhalant Allergens, 109/1844 (6%) for allergic asthma and 337/1602 (21%) for allergic rhinitis.']	N/A	N/A	[('CHEBI_61073', 'oxygen radical', 6, 'oxygen radical'), ('CHEBI_82625', 'Trolox', 50, 'Trolox'), ('CHEBI_33663', 'cyclic hydrocarbon', 353, 'allergens')]
PMC5485024	3/2017	S104-PMC5485024	['total antioxidant capacity Intake (μmol Trolox equivalents/day) as measured with Oxygen Radical absorbance capacity assay, energy‐adjusted to 1900 kcal/day.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 27, 'intake'), ('CHEBI_82625', 'Trolox', 40, 'Trolox'), ('CHEBI_61073', 'oxygen radical', 81, 'oxygen radical')]
PMC555773	9/2004	S219-PMC555773	['physiological concentrations of angiotensin ii activate Nad(P)H oxidase and trigger Free Radical Generation (especially that ofo2−⋅).']	N/A	N/A	[('CHEBI_13392', 'NAD(P)H', 56, 'NAD(P)H'), ('3', 'A2MP1', 59, '(P'), ('CHEBI_26519', 'radical', 84, 'free radical'), ('GO_0009952', 'anterior/posterior pattern specification', 84, 'free radical generation'), ('CHEBI_82625', 'Trolox', 129, '−⋅).')]
